Quality, availability and suitability of antimicrobial stewardship guidance : a multinational qualitative study
© The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy..
Background: Antimicrobial stewardship (AMS) programmes are established across the world to treat infections efficiently, prioritize patient safety, and reduce the emergence of antimicrobial resistance. One of the core elements of AMS programmes is guidance to support and direct physicians in making efficient, safe and optimal decisions when prescribing antibiotics. To optimize and tailor AMS, we need a better understanding of prescribing physicians' experience with AMS guidance.
Objectives: To explore the prescribing physicians' user experience, needs and targeted improvements of AMS guidance in hospital settings.
Methods: Semi-structured interviews were conducted with 36 prescribing physicians/AMS guidance users from hospital settings in Canada, Germany, Israel, Latvia, Norway and Sweden as a part of the international PILGRIM trial. A socioecological model was applied as an overarching conceptual framework for the study.
Results: Research participants were seeking more AMS guidance than is currently available to them. The most important aspects and targets for improvement of AMS guidance were: (i) quality of guidelines; (ii) availability of infectious diseases specialists; and (iii) suitability of AMS guidance to department context.
Conclusions: Achieving prudent antibiotic use not only depends on individual and collective levels of commitment to follow AMS guidance but also on the quality, availability and suitability of the guidance itself. More substantial commitment from stakeholders is needed to allocate the required resources for delivering high-quality, available and relevant AMS guidance to make sure that the prescribers' AMS needs are met.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
JAC-antimicrobial resistance - 6(2024), 2 vom: 30. März, Seite dlae039 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Linde-Ozola, Zane [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 16.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/jacamr/dlae039 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369763432 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369763432 | ||
| 003 | DE-627 | ||
| 005 | 20240316233101.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jacamr/dlae039 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1332.xml |
| 035 | |a (DE-627)NLM369763432 | ||
| 035 | |a (NLM)38486662 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Linde-Ozola, Zane |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Quality, availability and suitability of antimicrobial stewardship guidance |b a multinational qualitative study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. | ||
| 520 | |a Background: Antimicrobial stewardship (AMS) programmes are established across the world to treat infections efficiently, prioritize patient safety, and reduce the emergence of antimicrobial resistance. One of the core elements of AMS programmes is guidance to support and direct physicians in making efficient, safe and optimal decisions when prescribing antibiotics. To optimize and tailor AMS, we need a better understanding of prescribing physicians' experience with AMS guidance | ||
| 520 | |a Objectives: To explore the prescribing physicians' user experience, needs and targeted improvements of AMS guidance in hospital settings | ||
| 520 | |a Methods: Semi-structured interviews were conducted with 36 prescribing physicians/AMS guidance users from hospital settings in Canada, Germany, Israel, Latvia, Norway and Sweden as a part of the international PILGRIM trial. A socioecological model was applied as an overarching conceptual framework for the study | ||
| 520 | |a Results: Research participants were seeking more AMS guidance than is currently available to them. The most important aspects and targets for improvement of AMS guidance were: (i) quality of guidelines; (ii) availability of infectious diseases specialists; and (iii) suitability of AMS guidance to department context | ||
| 520 | |a Conclusions: Achieving prudent antibiotic use not only depends on individual and collective levels of commitment to follow AMS guidance but also on the quality, availability and suitability of the guidance itself. More substantial commitment from stakeholders is needed to allocate the required resources for delivering high-quality, available and relevant AMS guidance to make sure that the prescribers' AMS needs are met | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Classen, Annika Y |e verfasserin |4 aut | |
| 700 | 1 | |a Giske, Christian G |e verfasserin |4 aut | |
| 700 | 1 | |a Göpel, Siri |e verfasserin |4 aut | |
| 700 | 1 | |a Eliakim-Raz, Noa |e verfasserin |4 aut | |
| 700 | 1 | |a Semret, Makeda |e verfasserin |4 aut | |
| 700 | 1 | |a Simonsen, Gunnar Skov |e verfasserin |4 aut | |
| 700 | 1 | |a Vehreschild, Jörg Janne |e verfasserin |4 aut | |
| 700 | 1 | |a Jørgensen, Silje Bakken |e verfasserin |4 aut | |
| 700 | 1 | |a Kessel, Johanna |e verfasserin |4 aut | |
| 700 | 1 | |a Kleppe, Lars Kåre Selland |e verfasserin |4 aut | |
| 700 | 1 | |a Oma, Dorthea Hagen |e verfasserin |4 aut | |
| 700 | 1 | |a Vehreschild, Maria J G T |e verfasserin |4 aut | |
| 700 | 1 | |a Vilde, Aija |e verfasserin |4 aut | |
| 700 | 1 | |a Dumpis, Uga |e verfasserin |4 aut | |
| 700 | 0 | |a PILGRIM study group |e verfasserin |4 aut | |
| 700 | 1 | |a Aldins, Pauls |e investigator |4 oth | |
| 700 | 1 | |a Zvirbulis, Viesturs |e investigator |4 oth | |
| 700 | 1 | |a Kjellander, Christian |e investigator |4 oth | |
| 700 | 1 | |a Asfeldt, Anne Mette |e investigator |4 oth | |
| 700 | 1 | |a Wåhlin, Hannes |e investigator |4 oth | |
| 700 | 1 | |a Akselsen, Per Espen |e investigator |4 oth | |
| 700 | 1 | |a Kaya, Merve |e investigator |4 oth | |
| 700 | 1 | |a Fein, Lucas J |e investigator |4 oth | |
| 700 | 1 | |a Biehl, Lena M |e investigator |4 oth | |
| 700 | 1 | |a Dietz, Thilo |e investigator |4 oth | |
| 700 | 1 | |a Albus, Kerstin |e investigator |4 oth | |
| 700 | 1 | |a Schulze, Nick |e investigator |4 oth | |
| 700 | 1 | |a Farowski, Fedja |e investigator |4 oth | |
| 700 | 1 | |a Conzelmann, Nadine |e investigator |4 oth | |
| 700 | 1 | |a Eisenbeis, Simone |e investigator |4 oth | |
| 700 | 1 | |a Leibovici, Leonard |e investigator |4 oth | |
| 700 | 1 | |a Samuel, Maayan Huberman |e investigator |4 oth | |
| 700 | 1 | |a Langusa, Elina |e investigator |4 oth | |
| 700 | 1 | |a Urbena, Jelena |e investigator |4 oth | |
| 700 | 1 | |a Jardin, Barbara Ann |e investigator |4 oth | |
| 700 | 1 | |a Mbuyi, Lylie |e investigator |4 oth | |
| 700 | 1 | |a Karlsson, Frida |e investigator |4 oth | |
| 700 | 1 | |a Myrbakk, Toni |e investigator |4 oth | |
| 700 | 1 | |a Hansen, Marte Tangeraas |e investigator |4 oth | |
| 700 | 1 | |a Torkehagen, Tina Fure |e investigator |4 oth | |
| 700 | 1 | |a Sætre, Silje Severine |e investigator |4 oth | |
| 700 | 1 | |a Jarodd, Anita Helene |e investigator |4 oth | |
| 700 | 1 | |a Oftedal, Sissel Frostad |e investigator |4 oth | |
| 700 | 1 | |a Dalheim, Anne |e investigator |4 oth | |
| 700 | 1 | |a Ebeling, Franziska |e investigator |4 oth | |
| 700 | 1 | |a Angelstein, Nina |e investigator |4 oth | |
| 700 | 1 | |a Proske, Susanna |e investigator |4 oth | |
| 700 | 1 | |a Sauer, Gabriel |e investigator |4 oth | |
| 700 | 1 | |a Blumberg, Christian |e investigator |4 oth | |
| 700 | 1 | |a Rüb, Alina |e investigator |4 oth | |
| 700 | 1 | |a Butzer, Sarina |e investigator |4 oth | |
| 700 | 1 | |a Quante, Markus |e investigator |4 oth | |
| 700 | 1 | |a Christopeit, Maximilian |e investigator |4 oth | |
| 700 | 1 | |a Wagner, Silvia |e investigator |4 oth | |
| 700 | 1 | |a Daitch, Vered |e investigator |4 oth | |
| 700 | 1 | |a Yaron, Yulia Maler |e investigator |4 oth | |
| 700 | 1 | |a Babich, Tanya |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t JAC-antimicrobial resistance |d 2019 |g 6(2024), 2 vom: 30. März, Seite dlae039 |w (DE-627)NLM308660234 |x 2632-1823 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2024 |g number:2 |g day:30 |g month:03 |g pages:dlae039 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jacamr/dlae039 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2024 |e 2 |b 30 |c 03 |h dlae039 | ||